GlaxoSmithKline to invest in five new factories for Africa

By Bizclik Editor

The UK’s biggest drugs manufacturer, GlaxoSmithKline Plc, is set to announce today a multi-million pound plan to increase its presence in Sub-Saharan Africa.

The decision shows confidence in the growth of the continent as the global drugs company moves to take advantage of the opportunities in Africa.

Andrew Witty, Chief Executive Officer of GlaxoSmithKline, was reported saying in the Sunday Telegraph newspaper that the continent was important for the British company’s long-term growth.

He said: “The transformation of Africa into a successful growth region is one area that we need to focus on.”

The company is poised to build up to five new factories creating hundreds of new jobs and is actively seeking sites in Ghana, Ethiopia and Rwanda.

It already has production facilities in South Africa, Nigeria and Kenya which accounts for around £500 million of the group’s annual sales, which totalled £26.5 billion in 2013.

GSK’s African plan is set to be unveiled at the EU-Africa Business Summit in Brussels.

Share

Featured Articles

Age of the CISO – a new chapter for cyber security

HE Dr Mohamed Al-Kuwaiti, Head of Cyber Security, UAE Government and Dr Aloysius Cheang, Chief Security Officer Huawei UAE, on the new age of the CISO

Exclusive: Making the UAE a global force in cybersecurity

His Excellency Dr Mohamed Al-Kuwaiti, Head of Cyber Security, UAE Government, on plans to build the world’s most secure digital society for a safer society

UAE cyber leaders – back to basics to prepare for the future

HE Dr Mohamed Al-Kuwaiti, Head of Cyber Security, UAE Government and Dr Aloysius Cheang, Chief Security Officer Huawei UAE, on the future of cybersecurity

Top 10: Procurement & Supply Chain LIVE speaker highlights

Leadership & Strategy

10 apps to improve wellbeing on World Mental Health Day

Leadership & Strategy

Meet the COO: Brook Sims of MAC Diversity Recruiters

Leadership & Strategy